Dr. Theodore W Collins, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 135 E M35, Gwinn, MI 49841 Phone: 906-346-9275 |
News Archive
The Wall Street Journal: "President Barack Obama made a final push for comprehensive health-care legislation, calling on lawmakers to schedule a vote in the next few weeks." Obama urged Congress to "press ahead with a comprehensive bill," which will involve using reconciliation. "But he didn't use the term reconciliation, instead calling for a simple 'up or down vote.'" He appealed to public frustration with insurance companies and emphasized that he had included GOP ideas into his plan (Meckler, 3/3).
New research led by Hana El-Samad of the University of California, San Francisco, and the Chan-Zuckerberg Biohub confirmed the beneficial use of an antiviral therapeutic called SARSNotch, which uses a combination of the SynNotch platform and de-novo designed protein binders. SARSNotch uses sentinel T cells to detect and mount a genetic response toward the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein.
Houston Methodist received FDA approval Saturday to become the first academic medical center in the nation to transfuse donated plasma from a recovered COVID-19 patient into a critically ill patient.
Infectex, a Russian biotech company in Maxwell Biotech Venture Fund's portfolio, announced today enrollment of the first patients in its Phase IIb-III clinical trial of SQ109 for MDR-TB. Infectex was founded in 2011 to develop and commercialize innovative products for the treatment of TB.
Two studies from an unusual research partnership at the University of Chicago appear to have resolved a long-standing dispute about the role of melanin in the eye. The studies, one published in the Proceedings of the National Academy of Sciences (PNAS) and one early online in the Journal of the American Chemical Society (JACS), also suggest a new way to prevent a common cause of blindness.
› Verified 6 days ago